Open mitochondrial research · Plain-language explainer

Published on Zenodo · October 16, 2026

Mitochondrial Dynamics and TCA-Cycle Claims Require Same-Condition Flux Evidence

Friedl, Andrew

Abstract

**Background:** Mitochondrial fusion, fission, oxygen-consumption and metabolomics readouts are often interpreted together as evidence that mitochondrial shape directly controls TCA-cycle efficiency. That interpretation can overrun the assays when morphology, respiration and TCA endpoints were not measured under the same dynamics perturbation.

**Objective:** This working paper asks whether public primary morphology/dynamics studies support direct fusion/fission control of TCA-cycle efficiency, or whether they currently justify only an assay boundary requiring same-condition TCA flux or metabolite measurement.

**Methods:** PubMed, PubMed Central, publisher records and the frozen concept-evidence archive were checked on 2026-10-11. Five complete public primary records were source-coded: propionic-aciduria kidney, residual triple-negative breast cancer, TM4SF5 mitochondria-lysosome contact sites, hypertrophic-cardiomyopathy energetics and Newcastle disease virus mitophagy. Endpoint classes were mitochondrial morphology/dynamics or structure, direct TCA flux, quantified TCA/metabolite evidence, respiration/OXPHOS and same-condition dynamics-to-TCA support. The analysis was a source-level evidence synthesis with no pooling, no effect-size estimation and no biological validation.

**Results:** The coded set contained 5 primary records. Four records contained explicit mitochondrial morphology/dynamics language, five contained TCA/metabolite or metabolic-endpoint language, four contained respiration/OXPHOS or energetics language, two contained direct TCA-flux language and one contained same-condition dynamics perturbation plus direct TCA-flux support. The strongest partial contradiction was the TNBC OPA1 study, which measured morphology, OXPHOS and isotope TCA flux; however, the same source also reported that Mdivi-1-induced elongation was insufficient to alter glycolytic or TCA flux. The remaining records supported an assay boundary by showing disease-context co-measurement, OXPHOS/TCA decoupling, flux measurement without fusion/fission causality, or viral-stress dynamics without matched TCA flux.

**Conclusions:** Public primary evidence supports a cautious assay-boundary claim rather than a broad direct-control claim. Dynamics-to-TCA language is licensed only when the same experimental condition includes an explicit morphology/fusion/fission perturbation and direct isotope-resolved TCA flux or quantified TCA-intermediate evidence. This synthesis is exploratory, non-causal and non-pooled; it does not estimate clinical benefit or validate a mitochondrial intervention.

Download the manuscript PDF

DOI: 10.5281/zenodo.23424316

Read the full paperRead the public summary

The paper at a glance

The question

Mitochondria constantly change shape. Those shape changes can matter, but a shape picture or oxygen-use test is not the same as measuring the TCA cycle, the cell's central fuel-processing pathway.

Main takeaway

Shape or dynamics language and metabolism language often appeared together. Direct TCA-cycle flux evidence appeared in only a subset. One breast cancer study gave the strongest direct evidence, but even there simple elongation was not enough to change TCA flux.

Important caution

The paper does not show that changing mitochondrial shape is a treatment, does not prove clinical benefit and does not estimate an effect size.

Why this matters

Mitochondria constantly change shape. Those shape changes can matter, but a shape picture or oxygen-use test is not the same as measuring the TCA cycle, the cell's central fuel-processing pathway.

How the research was done

The paper compared five public primary studies in kidney disease, breast cancer cells, liver cancer contact sites, mouse heart energetics and virus-infected tumor cells. The evidence came from animals and cells, not a new human trial.

What the researchers found

Shape or dynamics language and metabolism language often appeared together. Direct TCA-cycle flux evidence appeared in only a subset. One breast cancer study gave the strongest direct evidence, but even there simple elongation was not enough to change TCA flux.

What this does not prove

The paper does not show that changing mitochondrial shape is a treatment, does not prove clinical benefit and does not estimate an effect size.

What researchers should test next

The next useful test would change fusion or fission and measure labeled fuel flow through the TCA cycle in the same samples.

Helpful definitions

Key terms in plain English

MitochondriaStructures inside cells that convert fuel into energy the cell can use.

See the evidence

Visual findings

Visual finding 1. Figure 1 analysis process
Visual finding 2. Figure 2 concept summary

For non-specialists

What this could mean for patients and families

This is a research-methods paper. It should not be used to choose supplements, medications or cancer treatment. Its purpose is to help researchers avoid over-reading mitochondrial pictures or oxygen-use assays.

  • Did this study test a treatment in people?
  • No. It compared public laboratory and animal studies.
  • What is the main practical message?
  • Claims about mitochondrial shape controlling the TCA cycle need direct fuel-flow or metabolite measurements in the same experiment.
Create your Mito Map →Join Mito Map as a researcher →